PRIME MEDICINE, INC.

Analyst Reco. Prime Medicine, Inc.

Equities

PRME

US74168J1016

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
5.72 ^USD	+6.72%		+1.96%	-35.44%

Apr. 29	Prime Medicine Shares Jump After Application for Chronic Granulomatous Disease Treatment Gets FDA Clearance	MT
Apr. 29	Prime Medicine Gets FDA Clearance for PM359 IND Application	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Initiates Prime Medicine With Buy Rating, Price Target is $17	Apr. 22	MT
Chardan Initiates Prime Medicine at Buy With $17 Price Target	Apr. 22	MT
Wedbush Initiates Prime Medicine With Outperform Rating, $12 PT; Notes Positive Long-Term Outlook on Gene Editing Platform	Apr. 03	MT
Guggenheim Cuts Prime Medicine's Price Target to $20 From $24, Maintains Buy Rating	Mar. 05	MT
Morgan Stanley Cuts Price Target on Prime Medicine to $12 From $18, Keeps Equalweight Rating	Dec. 12	MT
BMO Capital Starts Prime Medicine at Outperform, $19 Price Target	23-10-09	MT
Jones Trading Starts Prime Medicine at Buy With $20 Price Target	23-09-06	MT
Morgan Stanley Adjusts Price Target on Prime Medicine to $19 From $21, Keeps Equalweight Rating	23-08-14	MT
Guggenheim Starts Prime Medicine at Buy With $24 Price Target	23-07-31	MT
Stifel Initiates Prime Medicine at Hold With $18 Price Target	23-04-18	MT
Morgan Stanley Adjusts Price Target on Prime Medicine to $21 From $23, Maintains Equal-Weight Rating	23-01-24	MT
Goldman Sachs Starts Prime Medicine at Neutral With $22 Price Target	22-11-14	MT
JPMorgan Starts Prime Medicine at Overweight With $27 Price Target	22-11-14	MT
Jefferies Starts Prime Medicine at Buy With $25 Price Target	22-11-14	MT
Morgan Stanley Starts Prime Medicine at Equalweight With $23 Price Target	22-11-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW